Genetically altered mice to evaluate glutathione homeostasis in health and disease

Kosower, 1978, The glutathione status of cells, Int. Rev. Cytol., 54, 109, 10.1016/S0074-7696(08)60166-7 Meister, 1983, Glutathione. Annu. Rev. Biochem., 52, 711, 10.1146/annurev.bi.52.070183.003431 Meister, 1988, Glutathione metabolism and its selective modification, J. Biol. Chem., 263, 17205, 10.1016/S0021-9258(19)77815-6 Watson, 2003, Redox state of glutathione and thioredoxin in differentiation and apoptosis, Biofactors, 17, 307, 10.1002/biof.5520170130 Jones, 2002, Redox potential of GSH/GSSG couple: assay and biological significance, Methods Enzymol., 348, 93, 10.1016/S0076-6879(02)48630-2 Lu, 1999, Regulation of hepatic glutathione synthesis: current concepts and controversies, FASEB J., 13, 1169, 10.1096/fasebj.13.10.1169 Meister, 1991, Glutathione deficiency produced by inhibition of its synthesis, and its reversal: applications in research and therapy, Pharmacol. Ther., 51, 155, 10.1016/0163-7258(91)90076-X Arthur, 2000, The glutathione peroxidases, Cell Mol. Life Sci., 57, 1825, 10.1007/PL00000664 Rinaldi, 2002, Reactive intermediates and the dynamics of glutathione transferases, Drug Metab. Dispos., 30, 1053, 10.1124/dmd.30.10.1053 Luthman, 1979, Glutathione-dependent hydrogen donor system for calf thymus ribonucleoside-diphosphate reductase, Proc. Natl. Acad. Sci. USA, 76, 2158, 10.1073/pnas.76.5.2158 Hogg, 2002, The biochemistry and physiology of S-nitrosothiols, Annu. Rev. Pharmacol. Toxicol., 42, 585, 10.1146/annurev.pharmtox.42.092501.104328 Lipton, 2001, S-Nitrosothiols signal the ventilatory response to hypoxia, Nature, 413, 171, 10.1038/35093117 Pompella, 2003, The changing faces of glutathione, a cellular protagonist, Biochem. Pharmacol., 66, 1499, 10.1016/S0006-2952(03)00504-5 Huang, 2002, Glutathionylation of proteins by glutathione disulfide S-oxide, Biochem. Pharmacol., 64, 1049, 10.1016/S0006-2952(02)01175-9 Oja, 2000, Modulation of glutamate receptor functions by glutathione, Neurochem. Int., 37, 299, 10.1016/S0197-0186(00)00031-0 Townsend, 2003, The importance of glutathione in human disease, Biomed. Pharmacother., 57, 145, 10.1016/S0753-3322(03)00043-X Soltaninassab, 2000, Multifaceted regulation of gamma-glutamylcysteine synthetase, J. Cell Physiol., 182, 163, 10.1002/(SICI)1097-4652(200002)182:2<163::AID-JCP4>3.0.CO;2-1 Yang, 2002, Initial characterization of the glutamate–cysteine ligase modifier subunit Gclm(−/−) knockout mouse: novel model system for a severely compromised oxidative stress response, J. Biol. Chem., 277, 49446, 10.1074/jbc.M209372200 Fraser, 2002, Drosophila melanogaster glutamate–cysteine ligase activity is regulated by a modifier subunit with a mechanism of action similar to that of the mammalian form, J. Biol. Chem., 277, 1158, 10.1074/jbc.M106683200 Huang, 1993, Amino acid sequence and function of the light subunit of rat kidney gamma-glutamylcysteine synthetase, J. Biol. Chem., 268, 20578, 10.1016/S0021-9258(20)80764-9 Tu, 1998, Identification of an important cysteine residue in human glutamate–cysteine ligase catalytic subunit by site-directed mutagenesis, Biochem. J., 336, 675, 10.1042/bj3360675 Wild, 2000, Regulation of gamma-glutamylcysteine synthetase subunit gene expression: insights into transcriptional control of antioxidant defenses, Free Radic. Res., 32, 281, 10.1080/10715760000300291 Bea, 2003, Induction of glutathione synthesis in macrophages by oxidized low-density lipoproteins is mediated by consensus antioxidant response elements, Circ. Res., 92, 386, 10.1161/01.RES.0000059561.65545.16 Moellering, 1999, The induction of GSH synthesis by nanomolar concentrations of NO in endothelial cells: a role for gamma-glutamylcysteine synthetase and gamma-glutamyl transpeptidase, FEBS Lett., 448, 292, 10.1016/S0014-5793(99)00371-3 Levonen, 2001, Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells, Arterioscler. Thromb. Vasc. Biol., 21, 1846, 10.1161/hq1101.098488 Liu, 1998, Gamma-glutamylcysteine synthetase: mRNA stabilization and independent subunit transcription by 4-hydroxy-2-nonenal\, Am. J. Physiol., 275, L861 Dickinson, 2002, 4-Hydroxynonenal induces glutamate cysteine ligase through JNK in HBE1 cells, Free Radic. Biol. Med., 33, 974, 10.1016/S0891-5849(02)00991-7 Solis, 2002, Glutamate–cysteine ligase modifier subunit: mouse Gclm gene structure and regulation by agents that cause oxidative stress, Biochem. Pharmacol., 63, 1739, 10.1016/S0006-2952(02)00897-3 Dalton, 1999, Regulation of gene expression by reactive oxygen, Annu. Rev. Pharmacol. Toxicol., 39, 67, 10.1146/annurev.pharmtox.39.1.67 Itoh, 1997, An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements, Biochem. Biophys. Res. Commun., 236, 313, 10.1006/bbrc.1997.6943 McMahon, 2001, The Cap‘n’Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes, Cancer Res., 61, 3299 Chanas, 2002, Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice, Biochem. J., 365, 405, 10.1042/bj20020320 Dahl, 2001, Cell-type specific differences in glutamate cysteine ligase transcriptional regulation demonstrate independent subunit control, Toxicol. Sci., 61, 265, 10.1093/toxsci/61.2.265 Dethmers, 1981, Glutathione export by human lymphoid cells: depletion of glutathione by inhibition of its synthesis decreases export and increases sensitivity to irradiation, Proc. Natl. Acad. Sci. USA, 78, 7492, 10.1073/pnas.78.12.7492 Naganuma, 1990, Cellular glutathione as a determinant of sensitivity to mercuric chloride toxicity: prevention of toxicity by giving glutathione monoester, Biochem. Pharmacol., 40, 693, 10.1016/0006-2952(90)90303-3 Singhal, 1987, Glutathione, a first line of defense against cadmium toxicity, FASEB J., 1, 220, 10.1096/fasebj.1.3.2887478 Roizin-Towle, 1985, Selective enhancement of hypoxic cell killing by melphalan via thiol depletion: in vitro studies with hypoxic cell sensitizers and buthionine sulfoximine, J. Natl. Cancer Inst., 74, 151 Anderson, 1990, Protection against cisplatin toxicity by administration of glutathione ester, FASEB J., 4, 3251, 10.1096/fasebj.4.14.2227215 Ishikawa, 1990, The deleterious effect of buthionine sulfoximine, a glutathione-depleting agent, on the cisplatin toxicity in mice, Jpn. J. Pharmacol., 52, 652, 10.1254/jjp.52.652 Ishikawa, 1990, Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice, Res. Commun. Chem. Pathol. Pharmacol., 67, 131 Ishikawa, 1989, Injurious effect of buthionine sulfoximine, an inhibitor of glutathione biosynthesis, on the lethality and urotoxicity of cyclophosphamide in mice, Jpn. J. Pharmacol., 51, 146, 10.1254/jjp.51.146 Ishikawa, 1989, Modification of cyclophosphamide-induced urotoxicity by buthionine sulfoximine and disulfiram in mice, Res. Commun. Chem. Pathol. Pharmacol., 65, 265 Martensson, 1989, Mitochondrial damage in muscle occurs after marked depletion of glutathione and is prevented by giving glutathione monoester, Proc. Natl. Acad. Sci. USA, 86, 471, 10.1073/pnas.86.2.471 Ristoff, 1998, Patients with genetic defects in the gamma-glutamyl cycle, Chem. Biol. Interact., 111/112, 113, 10.1016/S0009-2797(97)00155-5 Beutler, 1999, The molecular basis of a case of gamma-glutamylcysteine synthetase deficiency, Blood, 94, 2890, 10.1182/blood.V94.8.2890.420k16_2890_2894 Ristoff, 2000, A missense mutation in the heavy subunit of gamma-glutamylcysteine synthetase gene causes hemolytic anemia, Blood, 95, 2193 Hamilton, 2003, A novel missense mutation in the gamma-glutamylcysteine synthetase catalytic subunit gene causes both decreased enzymatic activity and glutathione production, Blood, 102, 725, 10.1182/blood-2002-11-3622 Ristoff, 2002, Glutathione synthetase deficiency: is gamma-glutamylcysteine accumulation a way to cope with oxidative stress in cells with insufficient levels of glutathione?, J. Inherit. Metab. Dis., 25, 577, 10.1023/A:1022095324407 Wright, 1980, Glutathionuria: gamma-glutamyl transpeptidase deficiency, J. Inherit. Metab. Dis., 2, 3, 10.1007/BF01805554 Koide, 2003, Association of polymorphism in glutamate–cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction, J. Am. Coll. Cardiol., 41, 539, 10.1016/S0735-1097(02)02866-8 Kugiyama, 2001, Glutathione attenuates coronary constriction to acetylcholine in patients with coronary spastic angina, Am. J. Physiol. Heart Circ. Physiol., 280, H264, 10.1152/ajpheart.2001.280.1.H264 Prasad, 1999, Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability, J. Am. Coll. Cardiol., 34, 507, 10.1016/S0735-1097(99)00216-8 Nakamura, 2002, Polymorphism in the 5′-flanking region of human glutamate–cysteine ligase modifier subunit gene is associated with myocardial infarction, Circulation, 105, 2968, 10.1161/01.CIR.0000019739.66514.1E Nakamura, 2003, Polymorphism in glutamate–cysteine ligase modifier subunit gene is associated with impairment of nitric oxide-mediated coronary vasomotor function, Circulation, 108, 1425, 10.1161/01.CIR.0000091255.63645.98 Shi, 2000, Glutathione synthesis is essential for mouse development but not for cell growth in culture, Proc. Natl. Acad. Sci. USA, 97, 5101, 10.1073/pnas.97.10.5101 Dalton, 2000, Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene: embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous, Biochem. Biophys. Res. Commun., 279, 324, 10.1006/bbrc.2000.3930 Lieberman, 1996, Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice, Proc. Natl. Acad. Sci. USA, 93, 7923, 10.1073/pnas.93.15.7923 Rojas, 2000, Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase, Mutat. Res., 447, 305, 10.1016/S0027-5107(99)00191-8 Chevez-Barrios, 2000, Cataract development in gamma-glutamyl transpeptidase-deficient mice, Exp. Eye Res., 71, 575, 10.1006/exer.2000.0913 Will, 2000, Gamma-glutamyltranspeptidase-deficient knockout mice as a model to study the relationship between glutathione status, mitochondrial function, and cellular function, Hepatology, 32, 740, 10.1053/jhep.2000.17913 Barrios, 2001, Oxygen-induced pulmonary injury in gamma-glutamyl transpeptidase-deficient mice, Lung, 179, 319, 10.1007/s004080000071 Kletzien, 1994, Glucose-6-phosphate dehydrogenase: a “housekeeping” enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress, FASEB J., 8, 174, 10.1096/fasebj.8.2.8119488 Lee, 2002, Cytosolic NADP(+)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells, Free Radic. Biol. Med., 32, 1185, 10.1016/S0891-5849(02)00815-8 Bizouarn, 2000, The transmembrane domain and the proton channel in proton-pumping transhydrogenases, Biochim. Biophys. Acta, 1459, 284, 10.1016/S0005-2728(00)00163-8 Shin, 1998, Pyridine nucleotide levels in liver of rats fed clofibrate- or pyrazinamide-containing diets, Biochem. Pharmacol., 55, 367, 10.1016/S0006-2952(97)00507-8 Lee, 2003, Inactivation of NADP+-dependent isocitrate dehydrogenase by peroxynitrite: implications for cytotoxicity and alcohol-induced liver injury, J. Biol. Chem., 278, 51360, 10.1074/jbc.M302332200 Shertzer, 2004, CYP1A2 protects against reactive oxygen production in mouse liver microsomes, Free Radic. Biol. Med., 36, 605, 10.1016/j.freeradbiomed.2003.11.013 Shertzer, 2004, Uncoupling-mediated generation of reactive oxygen by halogenated aromatic hydrocarbons in mouse liver microsomes, Free Radic. Biol. Med., 36, 618, 10.1016/j.freeradbiomed.2003.11.014 Schlezinger, 1999, Oxidative inactivation of cytochrome P-450 1A (CYP1A) stimulated by 3,3′,4,4′-tetrachlorobiphenyl: production of reactive oxygen by vertebrate CYP1As, Mol. Pharmacol., 56, 588, 10.1124/mol.56.3.588 Lassegue, 2003, Vascular NAD(P)H oxidases: specific features, expression, and regulation, Am. J. Physiol. Regul. Integr. Comp. Physiol., 285, R277, 10.1152/ajpregu.00758.2002 Babior, 2002, The neutrophil NADPH oxidase, Arch. Biochem. Biophys., 397, 342, 10.1006/abbi.2001.2642 Forman, 2002, Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling, Am. J. Respir. Crit. Care Med., 166, S4, 10.1164/rccm.2206007 Harrison, 2002, Structure and function of xanthine oxidoreductase: where are we now?, Free Radic. Biol. Med., 33, 774, 10.1016/S0891-5849(02)00956-5 Dalton, 2003, Redox regulation of gene expression: transcriptional induction of heme oxygenase-1, 333 Schafer, 2001, Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple, Free Radic. Biol. Med., 30, 1191, 10.1016/S0891-5849(01)00480-4 Jones, 2002, Redox potential of GSH/GSSG couple: assay and biological significance, Methods Enzymol., 348, 93, 10.1016/S0076-6879(02)48630-2 Senft, 2000, Determining glutathione and glutathione disulfide using the fluorescence probe o-phthalaldehyde, Anal. Biochem., 280, 80, 10.1006/abio.2000.4498 Dafré, 1996, Protein S-thiolation and regulation of microsomal glutathione transferase activity by the glutathione redox couple, Arch. Biochem. Biophys., 332, 288, 10.1006/abbi.1996.0344 Solis, 2002, Glutamate–cysteine ligase modifier subunit: mouse Gclm gene structure and regulation by agents that cause oxidative stress, Biochem. Pharmacol., 63, 1739, 10.1016/S0006-2952(02)00897-3 Yang, 2002, Initial characterization of the glutamate–cysteine ligase modifier subunit Gclm(−/−) knockout mouse: novel model system for a severely compromised oxidative stress response, J. Biol. Chem., 277, 49446, 10.1074/jbc.M209372200 Watson, 2003, Oxidation of nuclear thioredoxin during oxidative stress, FEBS Lett., 543, 144, 10.1016/S0014-5793(03)00430-7 Rahman, 2000, Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches, Free Radic. Biol. Med., 28, 1405, 10.1016/S0891-5849(00)00215-X Sen, 1996, Antioxidant and redox regulation of gene transcription, FASEB J., 10, 709, 10.1096/fasebj.10.7.8635688 Jonas, 2002, Extracellular thiol/disulfide redox state affects proliferation rate in a human colon carcinoma (Caco2) cell line, Free Radic. Biol. Med., 33, 1499, 10.1016/S0891-5849(02)01081-X Armstrong, 2002, Glutathione depletion enforces the mitochondrial permeability transition and causes cell death in Bcl-2 overexpressing HL60 cells, FASEB J., 16, 1263, 10.1096/fj.02-0097fje Nkabyo, 2002, Glutathione and thioredoxin redox during differentiation in human colon epithelial (Caco-2) cells, Am. J. Physiol. Gastrointest. Liver Physiol., 283, G1352, 10.1152/ajpgi.00183.2002 Voehringer, 1999, BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity, Free Radic. Biol. Med., 27, 945, 10.1016/S0891-5849(99)00174-4 Moriarty, 2003, Oxidation of glutathione and cysteine in human plasma associated with smoking, Free Radic. Biol. Med., 35, 1582, 10.1016/j.freeradbiomed.2003.09.006